- Home
- MTA vs ARAY Comparison
MTA vs ARAY Comparison
Compare MTA & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTA
- ARAY
- Stock Information
- Founded
- MTA 1983
- ARAY 1990
- Country
- MTA Canada
- ARAY United States
- Employees
- MTA N/A
- ARAY N/A
- Industry
- MTA
- ARAY Medical/Dental Instruments
- Sector
- MTA
- ARAY Health Care
- Exchange
- MTA Nasdaq
- ARAY Nasdaq
- Market Cap
- MTA 279.4M
- ARAY 229.3M
- IPO Year
- MTA N/A
- ARAY 2007
- Fundamental
- Price
- MTA $3.65
- ARAY $1.22
- Analyst Decision
- MTA Hold
- ARAY
- Analyst Count
- MTA 1
- ARAY 0
- Target Price
- MTA $4.50
- ARAY N/A
- AVG Volume (30 Days)
- MTA 369.8K
- ARAY 1.1M
- Earning Date
- MTA 05-16-2025
- ARAY 04-30-2025
- Dividend Yield
- MTA N/A
- ARAY N/A
- EPS Growth
- MTA N/A
- ARAY N/A
- EPS
- MTA N/A
- ARAY 0.01
- Revenue
- MTA $6,348,000.00
- ARAY $465,251,000.00
- Revenue This Year
- MTA $125.91
- ARAY $3.87
- Revenue Next Year
- MTA $58.98
- ARAY $0.09
- P/E Ratio
- MTA N/A
- ARAY $183.07
- Revenue Growth
- MTA 30.38
- ARAY 8.06
- 52 Week Low
- MTA $2.32
- ARAY $1.14
- 52 Week High
- MTA $4.08
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- MTA 64.55
- ARAY 29.56
- Support Level
- MTA $3.56
- ARAY $1.24
- Resistance Level
- MTA $3.84
- ARAY $1.31
- Average True Range (ATR)
- MTA 0.16
- ARAY 0.07
- MACD
- MTA 0.05
- ARAY -0.04
- Stochastic Oscillator
- MTA 80.21
- ARAY 15.69
About MTA Metalla Royalty & Streaming Ltd.
Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.